Surgery (Austin & Northern Health) - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/187

Filters

2020 - 2021 5
5
Reset filters

Settings
Statistics
Citations
Start date: 2020 × Author: O'Connor, Ellen ×

Search Results

Now showing 1 - 5 of 5
  • Item
    Thumbnail Image
    Discussion: doctor-in-training delivered telehealth consultations, a safe and supported environment for clinical education
    Timm, B ; Jayarajan, J ; Liodakis, P ; O'Connor, E ; Bolton, D (WILEY, 2020-12)
  • Item
    Thumbnail Image
    Pitfalls of FDG-PET in the prostate for the surgical oncologist
    O'Connor, E ; Teh, J ; Bolton, D (ELSEVIER SCIENCE INC, 2020-11)
    A 78-year-old man was referred for investigation of prostate cancer following incidental uptake on 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). Despite normal PSA and benign digital rectal exam, he was referred for consideration of trans-perineal biopsy to exclude prostate cancer. It was only on review of imaging that it became clearly apparent that the 18F-FDG uptake was due to urinary tracer pooling in a trans-urethral resection cavity. Surgeons, oncologists and nuclear medicine physicians should be aware of this common pitfall in interpretation of 18F-FDG-PET in the prostate.
  • Item
    No Preview Available
    Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
    Teh, J ; O'Connor, E ; Coles-Black, J ; Lawrentschuk, N (SPRINGER, 2021-09)
    The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology. The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology.
  • Item
    Thumbnail Image
    Bacillus Calmette Guerin (BCG) vaccination use in the fight against COVID-19-what's old is new again?
    O'Connor, E ; Teh, J ; Kamat, AM ; Lawrentschuk, N (FUTURE MEDICINE LTD, 2020-07)
  • Item
    Thumbnail Image
    Robot-assisted ipsilateral ureteroureterostomy in a duplex system utilizing intraoperative flexible ureteroscopy
    O'Connor, E ; Teh, J ; Lawrentschuk, N (ELSEVIER SCIENCE INC, 2020-07)
    Iatrogenic injury to the ureter during pelvic surgery is an uncommon but well-documented complication. Accurate identification of the ureter during pelvic surgery is made far more complex in the presence of a duplex or ectopic system, an anomaly occurring in up to 2% of the population. In this article we present a technique for robot-assisted ipsilateral ureteroureterostomy for treatment of iatrogenic injury of a lower pole moiety ureter in a complete duplex system.